Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-01-29 @ 3:08 AM
Study NCT ID:
NCT05978050
Status:
RECRUITING
Last Update Posted:
2024-08-28
First Post:
2023-07-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma
Sponsor:
Biotech Pharmaceutical Co., Ltd.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BPL-Nim-GC-3001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None